Pharmacelera develops proprietary Computer-Aided Drug Design software and provides access to its technology through flexible licensing options and computational chemistry services
Pharmacelera develops proprietary Computer-Aided Drug Design software and provides access to its technology through flexible licensing options and computational chemistry services. The company focuses on Quantum-Mechanics and Machine Learning for drug discovery, helping in various stages such as Target Identification, Hit-Identification, Hit-to-Lead, and Lead Optimization.